West Pharmaceutical Services opens its second manufacturing plant in China to expand presence in Asian markets.
West Pharmaceutical Services, a provider of solutions for injectable-drug administration, started up its compression-molding plant in the Shanghai Zhangjiang High-Tech Industrial Development Zone Qingpu Park in China. The new plant is adjacent to West’s injection-molding facility that was dedicated in September 2009.
The 11,900-m2 compression-molding plant manufactures components used for packaging injectable drugs, supplying customers primarily in China and the Asia-Pacific region. Construction began in June 2011.
In addition to the plants in Qingpu, West’s presence in the Asia-Pacific region includes a factory in Singapore and sales offices in Australia, China, India and Singapore. The company’s first manufacturing facility in India is under construction.
Source: West Pharmaceutical Services
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
New Cancer Research and Treatment Center in Development in London
May 1st 2025Aviva Capital Partners and developer Socius are investing £1 billion in a 12-acre site to be located at the London Cancer Hub next to The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust’s Sutton site.